Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation
- PMID: 15233756
- DOI: 10.1111/j.1460-9568.2004.03508.x
Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation
Abstract
In order to clarify the functional role of the isolectin B4 (IB4)-binding afferent pathway in the micturition reflex, we investigated the effects on bladder activity of intrathecal application of the IB4-saporin conjugate, a targeting cytotoxin that destroys neurons binding IB4. In rats, IB4-saporin (2.5 micro m) or vehicle was administered through an intrathecal catheter implanted at the level of the L6-S1 spinal cord. Three weeks after IB4-saporin administration, cystometry in conscious animals revealed a reduction in bladder overactive responses induced by intravesical capsaicin or ATP infusion without affecting normal voiding function. In histochemical studies, double staining for IB4 and saporin was detected in L6 dorsal root ganglia (DRG) neurons 2 days after the treatment. Three weeks after the treatment, the area in lamina II of the L6 spinal cord stained with IB4 was significantly reduced compared with the area stained in control rats. The staining in the L1 spinal cord was not affected. The percentage of neurons in the L6 DRG intensely labeled with IB4 was also reduced in IB4-saporin-treated rats. These results indicate that intrathecal treatment with the IB4-saporin conjugate at the level of L6-S1 spinal cord, which reduces IB4 afferent nerve terminal staining in lamina II of the L6 spinal cord as well as the number of IB4-binding neurons in L6 DRG, suppressed bladder overactivity induced by bladder irritation without affecting normal micturition. Thus targeting IB4-binding, non-peptidergic afferent pathways sensitive to capsaicin and adenosine 5'-triphosphate may be an effective treatment for overactivity and/or pain responses in the bladder.
Similar articles
-
IB4 afferent sprouting contributes to bladder dysfunction in spinal rats.Exp Neurol. 2008 Oct;213(2):293-302. doi: 10.1016/j.expneurol.2008.06.006. Epub 2008 Jun 17. Exp Neurol. 2008. PMID: 18602393
-
Elimination of rat spinal neurons expressing neurokinin 1 receptors reduces bladder overactivity and spinal c-fos expression induced by bladder irritation.Am J Physiol Renal Physiol. 2005 Mar;288(3):F466-73. doi: 10.1152/ajprenal.00274.2004. Am J Physiol Renal Physiol. 2005. PMID: 15692058
-
The majority of bladder sensory afferents to the rat lumbosacral spinal cord are both IB4- and CGRP-positive.Brain Res. 2005 Nov 16;1062(1-2):86-91. doi: 10.1016/j.brainres.2005.09.026. Epub 2005 Nov 2. Brain Res. 2005. PMID: 16263099
-
Neurochemical plasticity and the role of neurotrophic factors in bladder reflex pathways after spinal cord injury.Prog Brain Res. 2006;152:97-115. doi: 10.1016/S0079-6123(05)52007-7. Prog Brain Res. 2006. PMID: 16198696 Review.
-
Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury.Prog Brain Res. 2006;152:59-84. doi: 10.1016/S0079-6123(05)52005-3. Prog Brain Res. 2006. PMID: 16198694 Review.
Cited by
-
Afferent nerve regulation of bladder function in health and disease.Handb Exp Pharmacol. 2009;(194):91-138. doi: 10.1007/978-3-540-79090-7_4. Handb Exp Pharmacol. 2009. PMID: 19655106 Free PMC article. Review.
-
Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals.J Neurosci. 2018 Feb 28;38(9):2226-2245. doi: 10.1523/JNEUROSCI.3476-17.2018. Epub 2018 Feb 5. J Neurosci. 2018. PMID: 29431655 Free PMC article.
-
Purinoceptors as therapeutic targets for lower urinary tract dysfunction.Br J Pharmacol. 2006 Feb;147 Suppl 2(Suppl 2):S132-43. doi: 10.1038/sj.bjp.0706637. Br J Pharmacol. 2006. PMID: 16465177 Free PMC article. Review.
-
CD44 Signaling Mediates High Molecular Weight Hyaluronan-Induced Antihyperalgesia.J Neurosci. 2018 Jan 10;38(2):308-321. doi: 10.1523/JNEUROSCI.2695-17.2017. Epub 2017 Nov 24. J Neurosci. 2018. PMID: 29175954 Free PMC article.
-
Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.Pain. 2016 Aug;157(8):1773-1782. doi: 10.1097/j.pain.0000000000000581. Pain. 2016. PMID: 27075428 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources